SAN MATEO, Calif.--(BUSINESS WIRE)--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its ...
Presidio Medical stated that its “technology leverages the scientific principles discovered by Alan Hodgkin and Andrew Huxley, who were awarded the Nobel Prize in 1963 [and] has been trialed in over ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Presidio Medical, Inc., a clinical-stage medical device company developing a transformational Ultra Low Frequency (ULF™) neuromodulation platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback